pegaptanib
Selected indexed studies
- Pegaptanib. (, 2006) [PMID:34813254]
- Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review. (Clin Ther, 2006) [PMID:16490578]
- Pegaptanib sodium. (Nat Rev Drug Discov, 2005) [PMID:15770779]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pegaptanib. (2006) pubmed
- Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review. (2006) pubmed
- Pegaptanib sodium. (2005) pubmed
- Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. (2007) pubmed
- Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. (2005) pubmed
- Pegaptanib for the treatment of age-related macular degeneration. (2006) pubmed
- Pegaptanib sodium for the treatment of age-related macular degeneration. (2008) pubmed
- Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. (2006) pubmed
- Pegaptanib: a novel approach to ocular neovascularization. (2006) pubmed
- Pegaptanib sodium for ocular vascular disease. (2007) pubmed